Infectious Diseases News and Research

RSS

Poolbeg and University College Dublin sign an Option Agreement to license melioidosis vaccine candidate

Poolbeg Pharma, 'Poolbeg' or the 'Company', a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has signed an Option Agreement to licence MelioVac, a vaccine for melioidosis, with University College Dublin and its inventor, Associate Professor Siobhán McClean, through NovaUCD, the university's knowledge transfer office.

7 Dec 2021

Lunaphore to host inaugural Spatial Biology Week™ virtual meeting

Lunaphore today announced the events and activities planned around the inaugural Lunaphore Spatial Biology Week™, taking place virtually December 6-10, 2021.

From Lunaphore 7 Dec 2021

Risk factors for COVID-19 among US healthcare workers

Researchers from the CDC have investigated the risk posed to healthcare workers and which factors are most likely to lead to infection.

7 Dec 2021

SARS-CoV-2 Delta saliva viral load 15 times that of the wild type

Researchers hypothesize that a higher viral load of SARS-CoV-2 Delta variant in saliva contributes to its high transmissibility.

6 Dec 2021

Long-term exposure to air pollution linked to metabolic-associated fatty liver disease

Metabolic-associated fatty liver disease (MAFLD) is a growing global health challenge and poses a substantial economic burden. A large-scale epidemiologic study in China has identified links between long-term exposure to ambient air pollution and MAFLD.

6 Dec 2021

A case of post-vaccination MIS in an adult without prior SARS-CoV-2 infection

A new case study on the report of multisystem inflammatory syndrome (MISC) in a 22-year-old woman in South Korea after vaccination.

5 Dec 2021

Strict COVID anti-contagion policies can provide long-term health benefits

Researchers assess the short- and long-term benefits of these policies on health outcomes in the Chinese population.

5 Dec 2021

'Combination' adjuvant may boost the protective power of vaccines

Scientists at La Jolla Institute for Immunology and Massachusetts Institute of Technology, have found a possible way to improve the effectiveness of COVID-19 vaccines - and any vaccine.

4 Dec 2021

New nanoparticle adjuvant could help make vaccines more powerful

A common strategy to make vaccines more powerful is to deliver them along with an adjuvant - a compound that stimulates the immune system to produce a stronger response.

3 Dec 2021

Maternal anemia during pregnancy may increase risk of childhood anemia

Babies born to women with anemia during pregnancy have an increased risk of childhood anemia, according to a study carried out in rural India.

2 Dec 2021

Harvard Chan School and Vanke School of Public Health launch collaboration on educational, research initiatives

Harvard T.H. Chan School of Public Health and Vanke School of Public Health, Tsinghua University, today announced the launch of a collaboration on educational and research initiatives.

2 Dec 2021

Special collection of articles highlights China's response to covid-19

Today, The BMJ is launching a special collection of articles on China's response to covid-19 - what it was, how it worked, why traditional public health measures played such a vital role, and how other countries can learn from this experience to protect their populations, in particular in future pandemics.

2 Dec 2021

Preventing SARS-CoV-2 transmission at large indoor events

A new trial showed that indoor live events are not associated with an increased risk of SARS-CoV-2 infection, provided preventive interventions are in place.

2 Dec 2021

Novel set of immune cells may have the opposite effect in multiple sclerosis, other brain conditions

A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis (MS) and other brain inflammation-related conditions, according to a new study by Weill Cornell Medicine and NewYork-Presbyterian researchers.

1 Dec 2021

Study analyzes global COVID-19 vaccination rates among people living with HIV

COVID-19 vaccination is especially important for immunocompromised individuals, such as people living with HIV, who face higher risks of developing severe symptoms and dying from COVID-19.

1 Dec 2021

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. The study is funded by the Government of Canada through its COVID-19 Immunity Task Force.

1 Dec 2021

Study uncovers a promising drug candidate to minimize dyskinesia in Parkinson's patients

A new study from Texas Biomedical Research Institute (Texas Biomed) and collaborators has identified a promising drug candidate to minimize uncontrolled, erratic muscle movements, called dyskinesia, associated with Parkinson's disease.

1 Dec 2021

Study uncovers major disparities in preferred HIV medication uptake in low- and middle-income countries

A new study uncovered large and persistent disparities by sex and age in the uptake of a preferred HIV medication in low- and middle-income countries, potentially subjecting some women to worse HIV treatment outcomes if the situation is not corrected quickly.

30 Nov 2021

Natural COVID-19 infection offers protection from gamma and delta variants of SARS-CoV-2

Natural infection with COVID-19 offered protection from reinfection when the gamma and delta variants predominated, according to a new University of Michigan study that also provides levels of antibodies needed to protect against reinfections.

30 Nov 2021

Northwestern researchers continue to tackle every facet of COVID-19 pandemic

As the COVID-19 pandemic nears the two-year mark, Northwestern Medicine scientists continue to tackle every facet of the disease, from investigating coronavirus vaccines' potential for providing immunity against similar coronaviruses to developing novel rapid antigen-based tests and examining disparities in COVID-19 case and mortality rates in Chicago.

30 Nov 2021

Infectious Diseases News and Research

Poolbeg and University College Dublin sign an Option Agreement to license melioidosis vaccine candidate

Lunaphore to host inaugural Spatial Biology Week™ virtual meeting

Risk factors for COVID-19 among US healthcare workers

SARS-CoV-2 Delta saliva viral load 15 times that of the wild type

Long-term exposure to air pollution linked to metabolic-associated fatty liver disease

A case of post-vaccination MIS in an adult without prior SARS-CoV-2 infection

Strict COVID anti-contagion policies can provide long-term health benefits

'Combination' adjuvant may boost the protective power of vaccines

New nanoparticle adjuvant could help make vaccines more powerful

Maternal anemia during pregnancy may increase risk of childhood anemia

Harvard Chan School and Vanke School of Public Health launch collaboration on educational, research initiatives

Special collection of articles highlights China's response to covid-19

Preventing SARS-CoV-2 transmission at large indoor events

Novel set of immune cells may have the opposite effect in multiple sclerosis, other brain conditions

Study analyzes global COVID-19 vaccination rates among people living with HIV

Longer interval between COVID-19 mRNA vaccine doses leads to stronger immune response

Study uncovers a promising drug candidate to minimize dyskinesia in Parkinson's patients

Study uncovers major disparities in preferred HIV medication uptake in low- and middle-income countries

Natural COVID-19 infection offers protection from gamma and delta variants of SARS-CoV-2

Northwestern researchers continue to tackle every facet of COVID-19 pandemic

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News